NK细胞-微生物群相互作用生物标志物策略:促进前列腺癌管理
Sara Fanijavadi1,2, Torben Frøstrup Hansen2,3, Ahmed Hussein Zedan2
1Cancer Polyclinic, Levanger Hospital, 7601 Levanger, Norway.
Biomolecules
|February 26, 2025
概括
来自血液,口腔,尿液和便样本的自然杀手 (NK) 细胞表型和微生物群概况可能提供一种最小侵入性的方法来评估前列腺癌 (PCa) 活动,并指导个性化治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 微生物组研究的研究.
背景情况:
- 自然杀手 (NK) 细胞在前列腺癌 (PCa) 管理中的作用尚未完全理解.
- 血液中的NK细胞测量被提出为PCa查和结果预测的最小侵入性工具.
- 在PCa中各种NK细胞表型的临床意义尚不清楚.
研究的目的:
- 调查NK细胞表型和微生物组资料的联合特征是否可以作为PCa中NK细胞活性的替代标记.
- 探索一种最小侵入性的方法来评估瘤微环境中的NK细胞功能.
- 提高预后准确性,并为PCa患者指导个性化治疗策略.
主要方法:
- 在血液样本中分析NK细胞表型.
- 从口腔,尿液和便样本中分析微生物组合的概况.
- 与PCa状态和潜在瘤微环境活动相关联的NK细胞和微生物群签名.
主要成果:
- 该研究假设,结合NK细胞和微生物组的特征可以间接表明瘤内的NK细胞活性.
- 这种方法为评估NK细胞功能的侵入性瘤活检提供了切实可行的替代方案.
- 分析这些相互作用可以提高预后准确性,并为个性化治疗开发提供信息.
结论:
- 结合NK细胞表型和微生物组特征,有可能成为PCa管理的最小侵入性生物标志物.
- 这种综合方法可以提高预后能力,并个性化治疗策略.
- 需要进一步的前性研究来验证这些微创试验对PCa治疗结果的有效性.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...


